loadpatents
Patent applications and USPTO patent grants for Economides; Aris N..The latest application filed is for "methods for modifying a genome".
Patent | Date |
---|---|
Genetically modified rodent with an inducible ACVR1 mutation in exon 7 that causes ectopic bone formation Grant 11,419,319 - Hatsell , et al. August 23, 2 | 2022-08-23 |
Methods For Modifying A Genome App 20220220510 - Economides; Aris N. ;   et al. | 2022-07-14 |
Genetically modified mouse with an inducible ACVR1 gene with a mutant R206H exon 5 that has ectopic bone formation Grant RE49,121 - Economides , et al. July 5, 2 | 2022-07-05 |
Multifunctional alleles Grant 11,319,557 - Economides , et al. May 3, 2 | 2022-05-03 |
Anti-acvr1 Antibodies And Uses Thereof App 20210253716 - IDONE; Vincent J. ;   et al. | 2021-08-19 |
Methods of modifying genes in eukaryotic cells Grant 10,988,776 - Economides , et al. April 27, 2 | 2021-04-27 |
Multispecific Antigen-binding Molecules And Uses Thereof App 20210115132 - Papadopoulos; Nicholas J. ;   et al. | 2021-04-22 |
Treatment Of Fibrodysplasia Ossificans Progressiva App 20210061898 - Hatsell; Sarah J. ;   et al. | 2021-03-04 |
Rodents With Conditional ACVR1 Mutant Alleles App 20200229406 - Economides; Aris N. ;   et al. | 2020-07-23 |
Human Antibodies to GREM1 App 20200157194 - Economides; Aris N. ;   et al. | 2020-05-21 |
Tropism-Modified Recombinant Viral Particles and Uses Thereof for the Targeted Introduction of Genetic Material into Human Cells App 20200140492 - Sabin; Leah ;   et al. | 2020-05-07 |
Mice that produce hybrid antibodies Grant 10,640,800 - Murphy , et al. | 2020-05-05 |
Treatment of Fibrodysplasia Ossificans Progressiva App 20200115440 - Hatsell; Sarah J. ;   et al. | 2020-04-16 |
Fibrillin-1 Mutations For Modeling Neonatal Progeroid Syndrome With Congenital Lipodystrophy App 20200107527 - Hunt; Charleen ;   et al. | 2020-04-09 |
Mice that produce hybrid antibodies Grant 10,584,364 - Murphy , et al. | 2020-03-10 |
Fibrillin-1 mutations for modeling neonatal progeroid syndrome with congenital lipodystrophy Grant 10,548,302 - Hunt , et al. Fe | 2020-02-04 |
Conditional rodent Acvr1 mutant gene Grant 10,531,648 - Economides , et al. Ja | 2020-01-14 |
Genetically modified mice that produce hybrid antibodies Grant 10,526,630 - Murphy , et al. J | 2020-01-07 |
Multifunctional Alleles App 20190390230 - Economides; Aris N. ;   et al. | 2019-12-26 |
Rodent Model Of Fibrodysplasia Ossificans Progressiva App 20190380315 - HATSELL; Sarah J. ;   et al. | 2019-12-19 |
Method for making a genetically modified mouse with an inducible ACVR1 mutation that causes ectopic bone formation Grant 10,470,444 - Economides , et al. Nov | 2019-11-12 |
Rodent embryonic stem cell with conditional ACVR1 mutant alleles Grant 10,448,621 - Economides , et al. Oc | 2019-10-22 |
Multispecific Antigen-binding Molecules And Uses Thereof App 20190309061 - Papadopoulos; Nicholas J. ;   et al. | 2019-10-10 |
Multifunctional alleles Grant 10,392,633 - Economides , et al. A | 2019-08-27 |
Mice that produce hybrid antibodies Grant 10,378,038 - Murphy , et al. A | 2019-08-13 |
Mouse embryonic stem cells comprising a hybrid heavy chain immunoglobulin locus Grant 10,378,039 - Murphy , et al. A | 2019-08-13 |
Methods of making a nucleic acid encoding a human variable region Grant 10,378,037 - Murphy , et al. A | 2019-08-13 |
Human antibodies to GREM1 Grant 10,377,817 - Economides , et al. A | 2019-08-13 |
Mice that produce hybrid antibodies Grant 10,378,040 - Murphy , et al. A | 2019-08-13 |
Compositions and methods for modifying cells Grant 10,344,299 - Economides , et al. July 9, 2 | 2019-07-09 |
Treatment Of Fibrodysplasia Ossificans Progressiva App 20190153085 - Hatsell; Sarah J. ;   et al. | 2019-05-23 |
Methods of modifying eukaryotic cells Grant 10,227,625 - Murphy , et al. | 2019-03-12 |
Rodents With Conditional ACVR1 Mutant Alleles App 20190053473 - Economides; Aris N. ;   et al. | 2019-02-21 |
Rodents With Conditional ACVR1 Mutant Alleles App 20190045760 - Economides; Aris N. ;   et al. | 2019-02-14 |
Methods Of Modifying Genes In Eukaryotic Cells App 20180371493 - Economides; Aris N. ;   et al. | 2018-12-27 |
Rodents with Conditional ACVR1 Mutant Alleles App 20180263227 - Economides; Aris N. ;   et al. | 2018-09-20 |
Nucleic acid construct for making a genetically modified rodent with an inducible ACVR1 mutation that causes ectopic bone formation Grant 9,999,207 - Economides , et al. June 19, 2 | 2018-06-19 |
Treatment of Fibrodysplasia Ossificans Progressiva App 20180111983 - Hatsell; Sarah J. ;   et al. | 2018-04-26 |
Fibrillin-1 Mutations For Modeling Neonatal Progeroid Syndrome With Congenital Lipodystrophy App 20180027782 - Hunt; Charleen ;   et al. | 2018-02-01 |
Compositions and Methods for Modifying Cells App 20170260544 - Economides; Aris N. ;   et al. | 2017-09-14 |
Methods of making a nucleic acid encoding a human variable region Grant 9,708,635 - Murphy , et al. July 18, 2 | 2017-07-18 |
Method for detecting the replacement of an endogenous allele with a modified allele by homologous recombination in a mouse ES cell Grant 9,677,129 - Economides , et al. June 13, 2 | 2017-06-13 |
Rodents with Conditional Acvr1 Mutant Alleles App 20170042130 - Economides; Aris N. ;   et al. | 2017-02-16 |
Methods of modifying eukaryotic cells Grant 9,528,136 - Murphy , et al. December 27, 2 | 2016-12-27 |
Genetically modified mouse with an inducible Acvr1 gene with a mutant R206H exon 5 that has ectopic bone formation Grant 9,510,569 - Economides , et al. December 6, 2 | 2016-12-06 |
ES Cell-Derived Mice From Diploid Host Embryo Injection App 20160316728 - Poueymirou; William ;   et al. | 2016-11-03 |
Mice That Produce Hybrid Antibodies App 20160316731 - Murphy; Andrew J. ;   et al. | 2016-11-03 |
Treatment Of Fibrodysplasia Ossificans Progressiva App 20160319009 - Hatsell; Sarah J. ;   et al. | 2016-11-03 |
Methods of producing hybrid antibodies Grant 9,388,446 - Murphy , et al. July 12, 2 | 2016-07-12 |
Methods of producing hybrid antibodies Grant 9,382,567 - Murphy , et al. July 5, 2 | 2016-07-05 |
Methods of producing hybrid antibodies Grant 9,376,699 - Murphy , et al. June 28, 2 | 2016-06-28 |
Genetically modified mice that produce hybrid antibodies Grant 9,371,553 - Murphy , et al. June 21, 2 | 2016-06-21 |
Methods of producing hybrid antibodies Grant 9,353,394 - Murphy , et al. May 31, 2 | 2016-05-31 |
Treatment of Fibrodysplasia Ossificans Progressiva App 20160075772 - Hatsell; Sarah J. ;   et al. | 2016-03-17 |
Human Antibodies To Grem1 App 20160024195 - Economides; Aris N. ;   et al. | 2016-01-28 |
Method for genetically modifying isolated non-human mammalian cell by homologous recombination Grant 8,846,402 - Economides , et al. September 30, 2 | 2014-09-30 |
Rodents With Conditional Acvr1 Mutant Alleles App 20140283158 - Economides; Aris N. ;   et al. | 2014-09-18 |
Hybrid antibodies comprising human variable regions and mouse constant regions produced in a genetically modified mouse Grant 8,791,323 - Murphy , et al. July 29, 2 | 2014-07-29 |
Compositions and Methods for Modifying Cells App 20140178879 - ECONOMIDES; ARIS N. ;   et al. | 2014-06-26 |
Method for genetically modifying mouse embryonic stem cell by homologous recombination Grant 8,759,105 - Economides , et al. June 24, 2 | 2014-06-24 |
Methods Of Modifying Genes In Eukaryotic Cells App 20140155689 - Economides; Aris N. ;   et al. | 2014-06-05 |
Multifunctional Alleles App 20130302899 - Economides; Aris N. ;   et al. | 2013-11-14 |
Multispecific Antigen-binding Molecules And Uses Thereof App 20130243775 - PAPADOPOULOS; Nicholas J. ;   et al. | 2013-09-19 |
Methods of Modifying Eukaryotic Cells App 20130137101 - Economides; Aris N. ;   et al. | 2013-05-30 |
Human antibodies to human RANKL, encoding nucleic acids and methods of treatment Grant 8,414,890 - Martin , et al. April 9, 2 | 2013-04-09 |
Human Antibodies To Human Rankl App 20120114665 - Martin; Joel H. ;   et al. | 2012-05-10 |
Multifunctional Alleles App 20110104799 - Economides; Aris N. ;   et al. | 2011-05-05 |
ES Cell-Derived Mice From Diploid Host Embryo Injection App 20090271884 - POUEYMIROU; William ;   et al. | 2009-10-29 |
Methods of modifying eukaryotic cells App 20090055943 - Economides; Aris N. ;   et al. | 2009-02-26 |
Method for targeting transcriptionally active loci Grant 7,473,557 - Economides , et al. January 6, 2 | 2009-01-06 |
Methods of modifying genes in eukaryotic cells App 20070275466 - Economides; Aris N. ;   et al. | 2007-11-29 |
Therapeutic method for treating bone formation diseases Grant 7,285,532 - Economides , et al. October 23, 2 | 2007-10-23 |
Morphogenic protein Grant 7,241,739 - Valenzuela , et al. July 10, 2 | 2007-07-10 |
Genome mutation by intron insertion into an embryonic stem cell genome Grant 7,205,148 - Economides , et al. April 17, 2 | 2007-04-17 |
Methods of modifying eukaryotic cells App 20050144655 - Economides, Aris N. ;   et al. | 2005-06-30 |
Method for targeting transcriptionally active loci App 20050120401 - Economides, Aris N. ;   et al. | 2005-06-02 |
DCR-5 bone affecting ligand Grant 6,846,908 - Economides , et al. January 25, 2 | 2005-01-25 |
Methods of modifying genes in eukaryotic cells App 20050003543 - Economides, Aris N. ;   et al. | 2005-01-06 |
Therapeutic method for treating bone formation diseases App 20040132661 - Economides, Aris N. ;   et al. | 2004-07-08 |
DCR-5 bone affecting ligand App 20040106134 - Economides, Aris N. ;   et al. | 2004-06-03 |
DCR5, a BMP-binding protein, and applications thereof Grant 6,660,499 - Economides , et al. December 9, 2 | 2003-12-09 |
Novel morphogenic protein App 20030199042 - Valenzuela, David M. ;   et al. | 2003-10-23 |
Morphogenic proteins Grant 6,610,510 - Valenzuela , et al. August 26, 2 | 2003-08-26 |
Methods of modifying eukaryotic cells Grant 6,586,251 - Economides , et al. July 1, 2 | 2003-07-01 |
Methods of expressing transgenes App 20030084468 - Economides, Aris N. ;   et al. | 2003-05-01 |
Method for targeting transcriptionally active loci App 20030003581 - Economides, Aris N. ;   et al. | 2003-01-02 |
Methods of modifying eukaryotic cells App 20020106628 - Economides, Aris N. ;   et al. | 2002-08-08 |
CNTF and IL-6 antagonists Grant 5,470,952 - Stahl , et al. November 28, 1 | 1995-11-28 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.